• $46.9M
    Market Cap
  • 29.47%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
1.4M
+664.40%
178,992
N/A
Gross Profit
0
N/A
0
+100.00%
-1.4M
+664.40%
-178,992
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-10.2M
+258.52%
-2.9M
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
2.7M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
13.1M
+195.07%
4.4M
+223.56%
1.4M
+664.40%
178,992
N/A
Operating Profit
-13.1M
+195.07%
-4.4M
+182.06%
-1.6M
+529.96%
-249,146
N/A
Interest Income
1.4M
-62.75%
3.8M
+474.66%
654,071
+45,703.29%
1,428
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
1.4M
-62.75%
3.8M
+474.66%
654,071
+45,703.29%
1,428
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-13.1M
+195.07%
-4.4M
+383.58%
-915,456
+269.56%
-247,718
N/A
Income Taxes
838
+1,230.16%
63
-99.92%
80,648
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-13.1M
+195.09%
-4.4M
+344.43%
-996,104
+302.11%
-247,718
N/A
Net Income from Continuing Operations Applicable to Common
-13.1M
+195.07%
-4.4M
+383.58%
-915,456
+269.56%
-247,718
N/A
Basic EPS and Net Income
-0.35
+191.67%
-0.12
-77.78%
-0.54
-28.95%
-0.76
N/A
Diluted EPS and Net Income
-0.35
+191.67%
-0.12
-77.78%
-0.54
-171.05%
0.76
N/A
Basic Weighted Average Shares
36.8M
+0.84%
36.5M
+261.32%
10.1M
+756.94%
1.2M
N/A
Diluted Weighted Average Shares
36.8M
+0.84%
36.5M
+261.32%
10.1M
+756.94%
1.2M
N/A
Balance Sheet
Cash and Cash Equivalents
1.4M
+50.97%
916,916
+2,147.23%
40,802
-91.48%
478,868
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.4M
+50.97%
916,916
+2,147.23%
40,802
-91.48%
478,868
N/A
Total Current Assets
1.7M
+2.21%
1.6M
+3,029.64%
52,427
-91.49%
616,034
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
700,000
-92.76%
9.7M
-78.60%
45.2M
N/A
Total Assets
3.2M
+1.15%
3.1M
-67.70%
9.7M
-78.77%
45.8M
N/A
Income Taxes Payable
12.4M
+24,799,900.00%
50
-99.94%
80,648
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
50,000
N/A
N/A
N/A
Total Current Liabilities
13.5M
+351.88%
3.0M
+179.30%
1.1M
+1,366.86%
73,154
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
204,000
N/A
N/A
N/A
Total Long-Term Liabilities
356,505
N/A
0
-100.00%
58,944
-96.20%
1.6M
N/A
Total Liabilities
13.5M
+351.88%
3.0M
+12.97%
2.7M
+63.40%
1.6M
N/A
Retained Earnings
-37.0M
+54.60%
-23.9M
+960.69%
-2.3M
+124.16%
-1.0M
N/A
Total Stockholders Equity
-10.4M
-7,312.12%
143,731
+106.37%
-2.3M
+124.18%
-1.0M
N/A
Total Shares Outstanding
38.5M
+4.92%
36.7M
+2,483.71%
1.4M
0.00%
1.4M
N/A
Cash Flow
Cash from Operating Activities
-1.8M
-42.65%
-3.1M
+198.27%
-1.0M
+230.17%
-316,158
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
5.0M
-86.29%
36.2M
+180.05%
-45.2M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.3M
+1,769.11%
-134,986
-99.62%
-35.6M
-177.35%
46.0M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-413.55%
N/A
N/A
N/A
-3.59%
N/A
N/A
N/A
Return on Equity
255.59%
N/A
N/A
N/A
61.08%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.12
N/A
N/A
N/A
0.05
N/A
N/A
N/A
Cash Ratio
0.10
N/A
N/A
N/A
0.04
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
-0.11
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.03
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow